New eye scan study aims to unlock Glaucoma's secrets

NCT ID NCT06274593

Recruiting now Knowledge-focused Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 50 people with advanced glaucoma for three years, using a special eye scan (OCT angiography) to measure blood flow around the optic nerve. Researchers want to see how these scans compare with standard vision tests in tracking the disease. The goal is to better understand how glaucoma damages eyesight over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better predict how glaucoma progresses by using a non-invasive imaging test.
What could go wrong: This is a small, observational study with only 50 participants, so results may not apply to everyone. It is not testing a treatment, so it won't directly improve vision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA

Contacts and locations

Locations

CHU Nantes
RECRUITING

Nantes, Nantes, 44000, France
Jean-Baptiste Ducloyer
NOT_YET_RECRUITING

Nantes, Nantes, 44093, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.